Zhixiang Zhuang

Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial

Dan-Yun Ruan, Furong Liu, Xiao-Li Wei et al. · The Lancet Oncology · 2025 · 53 citations

Medicine, Oncology, Pharmacology +12

A comparative evaluation on prediction methods of nucleosome positioning

Hui Liu, Rui Zhang, Wenwei Xiong et al. · Briefings in Bioinformatics · 2013 · 30 citations · Full text

Life Sciences, Bioinformatics, Molecular Biology +14

Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development

Bo Wang, Huan Yang, Liqin Shen et al. · Cellular Physiology and Biochemistry · 2016 · 29 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Safety, Efficacy, and Pharmacokinetics of Rezivertinib (BPI-7711) in Patients With Advanced NSCLC With EGFR T790M Mutation: A Phase 1 Dose-Escalation and Dose-Expansion Study

Yuankai Shi, Yanqiu Zhao, Sheng Yang et al. · Journal of Thoracic Oncology · 2022 · 27 citations

Medicine, Pharmacokinetics, Pharmacology +13

<p>Dexamethasone inhibits the proliferation of tumor cells</p>

Yuantao Wu, Chungang Dai, Suji Yan et al. · Cancer Management and Research · 2019 · 25 citations · Full text

Medicine, Oncology, Pharmacology +11